gptkbp:instanceOf
|
gptkb:disease
|
gptkbp:affects
|
humans
|
gptkbp:causedBy
|
gptkb:Zika_virus
|
gptkbp:complication
|
gptkb:Guillain-Barré_syndrome
microcephaly
|
gptkbp:diagnosedBy
|
blood test
urine test
|
gptkbp:duration
|
2–7 days
|
gptkbp:firstDescribed
|
1952
|
https://www.w3.org/2000/01/rdf-schema#label
|
Zika fever
|
gptkbp:ICD-10_code
|
A92.5
|
gptkbp:incubationPeriod
|
3–14 days
|
gptkbp:mortalityRate
|
low
|
gptkbp:namedAfter
|
gptkb:Zika_Forest
|
gptkbp:notableOutbreaks
|
gptkb:2015–2016_Americas_outbreak
|
gptkbp:parent
|
arboviral disease
|
gptkbp:prevention
|
gptkb:entomologist
personal protective equipment
mosquito control
|
gptkbp:region
|
subtropical regions
tropical regions
|
gptkbp:riskFactor
|
mosquito bites
|
gptkbp:spreadTo
|
blood transfusion
sexual contact
pregnancy (mother to fetus)
|
gptkbp:symptom
|
fever
joint pain
conjunctivitis
rash
|
gptkbp:transmittedBy
|
gptkb:Aedes_mosquito
|
gptkbp:treatment
|
supportive care
rest
fluids
pain relievers
|
gptkbp:vaccineAvailable
|
no (as of 2024)
|
gptkbp:bfsParent
|
gptkb:Zika_Virus
|
gptkbp:bfsLayer
|
5
|